Long-term outcome of mitomycin C-augmented needle revision of trabeculectomy blebs for late trabeculectomy failure
- 29 August 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Eye
- Vol. 32 (12), 1893-1899
- https://doi.org/10.1038/s41433-018-0199-8
Abstract
To describe the 3-year outcomes of mitomycin C (MMC)-augmented bleb needling procedures following late trabeculectomy failure. A retrospective, observational chart review of 44 eyes that underwent MMC-augmented bleb needling following late trabeculectomy failure. The primary outcome measure was IOP at 3 years post-operatively. Secondary outcome measures were the number of topical glaucoma medications and success rate at 3 years. Success was defined on the basis of IOP (≤21 mmHg and ≥5 mmHg with a reduction of ≥ 20% from pre-operative baseline), need for ocular hypotensive medications, and need for further laser or surgical intervention. Mean IOP was reduced from 19.8 mmHg preoperatively to 13.9 mmHg (29.5% reduction) at 3 years. By the 3-year time point, 26 eyes (59.1%) had met one or more of the criteria for failure. A lower immediate post-operative IOP was found to be associated with greater likelihood of success. Bleb needling augmented with MMC can achieve a significant reduction in IOP in eyes with late trabeculectomy failure. By 3 years however, 59% of eyes were classified as failures, with half requiring further glaucoma surgery or laser. Patients undergoing this procedure should therefore be warned of the likelihood of requiring further intervention, and a repeat antimetabolite-augmented trabeculectomy or glaucoma tube shunt surgery in the first instance can be considered instead.This publication has 24 references indexed in Scilit:
- Early transconjunctival needling revision with 5-fluorouracil versus medical treatment in encapsulated blebs: a 12-month prospective studyClinics, 2013
- A Twenty-Year Follow-up Study of Trabeculectomy: Risk Factors and OutcomesOphthalmology, 2012
- Office-based slit-lamp needle revision with adjunctive Mitomycin-C for late failed or encapsulated filtering blebsMiddle East African Journal of Ophthalmology, 2012
- Long-term Outcomes of Needle Revision of Trabeculectomy Blebs With Mitomycin C and 5-FluorouracilJournal of Glaucoma, 2009
- Prospective Evaluation of Preoperative Factors Associated With Successful Mitomycin C Needling of Failed Filtration BlebsJournal of Glaucoma, 2006
- Long-term intraocular pressure control of eyes that developed encapsulated blebs following trabeculectomyEye, 2005
- Needle revision of failing and failed trabeculectomy blebs with adjunctive 5-fluorouracil*1Survival analysisOphthalmology, 2004
- Transconjunctival mitomycin-C in needle revisions of failing filtering blebsOphthalmology, 2003
- The treatment of encapsulated trabeculectomy blebs in an out-patient setting using a needling technique and subconjunctival 5-fluorouracil injectionEye, 1998
- Wound healing in glaucoma filtering surgerySurvey of Ophthalmology, 1987